AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Bonglip 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

AAR ESS Remedies Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Bonglip 50mg/500mg Tablet

Diabetica Duo 50mg/500mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This dual action helps prevent serious diabetic complications like vision impairment and kidney disease, potentially lowering heart attack and stroke risk. Diabetica Duo may be used independently or alongside other diabetes treatments. Optimal results are achieved with a healthy diet and regular physical activity. Dosage is personalized based on your health status, blood sugar readings, and existing medications. Taking it with food minimizes stomach upset. Consistent daily dosing is crucial for maximum effectiveness; discontinue only under your doctor's guidance. Adherence to your prescribed diet and exercise plan is essential. Lifestyle choices significantly impact diabetes control. Common side effects include nausea, diarrhea, vomiting, stomach discomfort, headache, and throat irritation. Low blood sugar (hypoglycemia) is a potential side effect, particularly when combined with insulin or sulfonylureas; learn to recognize and manage this risk. This medication isn't for everyone. Inform your doctor of any pre-existing kidney, liver, heart, or pancreatic issues, or excessive alcohol consumption before starting treatment. Pregnant or nursing individuals should consult their physician. Other medications may interact with Diabetica Duo; disclose all medications to ensure safety. Alcohol should be limited due to its blood sugar-lowering effects. Your doctor will monitor kidney function and blood glucose levels throughout treatment.

Primary Ingredients of Bonglip 50mg/500mg Tablet

The provided text is "undefined," offering no content to rephrase. Therefore, no rewritten text can be provided.

Uses of Bonglip 50mg/500mg Tablet

Managing Type 2 Diabetes

Major Benefits of Bonglip 50mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Bonglip 50mg/500mg Tablet whole; do not break, crush, or chew it. Administer this medicine with food.

Common Side effects of Bonglip 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Bonglip 50mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the Bonglip 50mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with food.

How Bonglip 50mg/500mg Tablet works:

Bonglip 50mg/500mg tablets combine sitagliptin and metformin to manage blood sugar. Sitagliptin boosts insulin production, enhances insulin effectiveness, and lessens the liver's glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. This dual action optimizes blood glucose regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Bonglip 50mg/500mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Bonglip 50mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers before recommending its use. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Bonglip 50mg/500mg tablets while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with excessively high or low blood glucose levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Bonglip 50mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Bonglip 50mg/500mg tablet use. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Patients with liver impairment should likely avoid Bonglip 50mg/500mg tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Bonglip 50mg/500mg Tablet :

Should you forget a Bonglip 50mg/500mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Bonglip 50mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Bonglip 50mg/500mg Tablet

Bonglip 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Bonglip 50mg/500mg Tablet can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Bonglip 50mg/500mg tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Bonglip 50mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Bonglip 50mg/500mg Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Bonglip 50mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Bonglip 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This combination is unsuitable for individuals under 18.
Bonglip 50mg/500mg tablets may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Bonglip 50mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Bonglip 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Bonglip 50mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from high blood lactic acid levels. This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Bonglip 50mg/500mg Tablet can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Bonglip 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Bonglip 50mg/500mg Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Bonglip 50mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Bonglip 50mg/500mg Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis), is a potential side effect of Bonglip 50mg/500mg Tablet. This condition, caused by excessive lactic acid in the blood, is rare but warrants caution, particularly in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms can include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience any of these, discontinue Bonglip and seek immediate medical attention.
Prolonged use of Bonglip 50mg/500mg Tablet can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Bonglip 50mg/500mg Tablet
178